(0.07%) 5 521.00 points
(0.11%) 39 889 points
(0.19%) 19 788 points
(0.00%) $81.63
(0.43%) $2.82
(-0.29%) $2 337.50
(0.02%) $29.53
(0.33%) $1 005.10
(0.01%) $0.932
(0.02%) $10.54
(0.01%) $0.788
(-2.06%) $86.18
6.15% $ 0.262
Live Chart Being Loaded With Signals
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients...
Stats | |
---|---|
Dzisiejszy wolumen | 8.32M |
Średni wolumen | 16.09M |
Kapitalizacja rynkowa | 14.51M |
EPS | $-0.450 ( Q3 | 2024-05-14 ) |
Następna data zysków | ( $0 ) 2024-09-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.110 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00100 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-30 | Johnson Laura L. | Buy | 8 500 | Options (Right to Buy) |
2023-08-30 | Favorito Tamara A | Buy | 8 500 | Options (Right to Buy) |
2023-08-30 | Hoffman Robert E. | Buy | 23 142 | Options (Right to Buy) |
2023-08-30 | Toth Robert Joseph Jr | Buy | 8 500 | Options (Right to Buy) |
2023-08-30 | Brown Dennis M | Buy | 10 175 | Options (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 96 transactions |
Buy: 12 848 509 | Sell: 15 566 |
Wolumen Korelacja
Kintara Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kintara Therapeutics, Korelacja - Waluta/Towar
Kintara Therapeutics, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-60 000.00 (0.00 %) |
EPS: | $-9.04 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-60 000.00 (0.00 %) |
EPS: | $-9.04 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-60 000.00 (0.00 %) |
EPS: | $-23.22 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-73.97 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Kintara Therapeutics,
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej